Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26072848 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nitzan Zohar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Hypercapnia, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, W. Kim Foster Pancreatic Pilot Research Grant, Newell Charitable trust.
Abstract (Originalsprache)
Hypercapnia is a key feature of the respiratory microenvironment in many pathologic conditions. It occurs both as a regional and as a systemic process, and it is associated with multiple metabolic changes such as mitochondrial dysfunction, decreased ATP production, and metabolic shift from glycolytic energy production to fatty acid metabolism. In the cancer tumor microenvironment, hypercapnia has been linked at times to enhanced cell migration, invasion, and chemoresistance. Our previous work has shown that hypercapnia-associated gene signatures can be used as prognostic biomarkers. However, unlike the hypoxia-inducible factor pathway, there are no validated targets to quantify hypercapnia. In this study, we investigated the phenotypic and transcriptomic changes occurring in pancreatic ductal adenocarcinoma (PDAC) due to chronic exposure to hypercapnic atmospheres. We then identified and validated SIAH3 as a hypercapnia-affected target and explored its clinical relevance as a prognostic factor in PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA.
ORCID-Profile: Aditi Jain, Charles J Yeo, Avinoam Nevler
Förderung
- NCI NIH HHS
- W. Kim Foster Pancreatic Pilot Research Grant
- Newell Charitable trust
- Newell Charitable Trust research grant from the Department of Surgery, TJU
- National Cancer Institute
Zitieren
APA
Zohar, N., Maguire, R., Khalilieh, S., Jain, A., Bosykh, D., Bowne, W. B., Lavu, H., Yeo, C. J., & Nevler, A. (2025). Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072848
Vancouver
Zohar N, Maguire R, Khalilieh S, Jain A, Bosykh D, Bowne WB, et al. Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072848
BibTeX
@article{Zohar2025,
author = {Zohar, Nitzan and Maguire, Ryan and Khalilieh, Saed and Jain, Aditi and Bosykh, Dmitriy and Bowne, Wilbur B and Lavu, Harish and Yeo, Charles J and Nevler, Avinoam},
title = {Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26072848}
}
EUVIMED